Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Sell
48
PKTX Quote, Financials, Valuation and Earnings
Last price:
$0.0100
Seasonality move
:
-11.37%
Day range:
$0.0066 - $0.0082
52-week range:
$0.0040 - $0.0149
Dividend yield:
0%
P/E ratio:
23.85x
P/S ratio:
--
P/B ratio:
13.02x
Volume:
10K
Avg. volume:
174.9K
1-year change:
-20.39%
Market cap:
$3.3M
Revenue:
--
EPS (TTM):
-$0.00
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Protokinetix, Inc. has -- downside to fair value with a price target of -- per share.
PKTX vs. S&P 500
-
Over the past 5 trading days, Protokinetix, Inc. has overperformed the S&P 500 by 61.94% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Protokinetix, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Protokinetix, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Protokinetix, Inc. reported revenues of --.
Earnings Growth
-
Protokinetix, Inc. has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Protokinetix, Inc. reported earnings per share of -$0.00.
Enterprise value:
3.2M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
-0.75x
EV / Free cash flow:
-14.60x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$51.6K
Return On Assets:
-77.54%
Net Income Margin (TTM):
--
Return On Equity:
-111.59%
Return On Invested Capital:
-111.59%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -$89.7K | -$54.3K | -$51.6K | -$15.1K | -$12.6K | |
| Operating Income | -$886.7K | -$374.1K | -$376.2K | -$84.6K | -$84.9K | |
| EBITDA | -$797K | -$319.9K | -$324.6K | -$69.4K | -$72.3K | |
| Diluted EPS | -$0.00 | -$0.00 | -$0.00 | -$0.00 | -$0.00 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $146.3K | $44.8K | $13.4K | $6.7K | $1.7K | |
| Total Assets | $485.8K | $479.7K | $450.9K | $479.3K | $477.6K | |
| Current Liabilities | $7K | $105K | $12.6K | $87.7K | $227.2K | |
| Total Liabilities | $7K | $105K | $12.6K | $87.7K | $227.2K | |
| Total Equity | $478.8K | $374.7K | $438.3K | $391.5K | $250.4K | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$445.7K | -$255.3K | -$181.2K | -$39.1K | -$3.9K | |
| Cash From Investing | -$92.1K | -$77.4K | -$41.4K | -$17.4K | -$5.6K | |
| Cash From Financing | $506.5K | $326K | $217.5K | $60K | $10K | |
| Free Cash Flow | -$537.9K | -$332.7K | -$222.6K | -$56.5K | -$9.5K | |
PKTX
Sector
Market Cap
$3.3M
$24M
Price % of 52-Week High
55.71%
48.22%
Dividend Yield
0%
0%
Shareholder Yield
-10.14%
-1.63%
1-Year Price Total Return
-24.55%
-22.68%
Beta (5-Year)
0.614
0.504
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$0.0064
200-day SMA
Buy
Level
$0.0071
Bollinger Bands (100)
Buy
Level
0.0061 - 0.0061
Chaikin Money Flow
Sell
Level
-1.1M
20-day SMA
Buy
Level
$0.0065
Relative Strength Index (RSI14)
Buy
Level
58.7084
ADX Line
Buy
Level
12.2901
Williams %R
Neutral
Level
-56.1644
50-day SMA
Buy
Level
$0.0060
MACD (12, 26)
Buy
Level
0.0020
25-day Aroon Oscillator
Buy
Level
40
On Balance Volume
Sell
Level
-1.7M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-129.7731)
Sell
CA Score
(Annual)
Level (-2.457)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (6.6491)
--
Piotroski F Score
(Annual)
Level (--)
Sell
Quality Ratio Score
Level (1)
Sell
Fundamental Score
Level (1)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Protokinetix, Inc. is a research and development stage biotechnology company engaged in the scientific medical research of anti-aging glycoproteins. The company was founded by Grant Young on December 23, 1999 and is headquartered in Dalton, OH.
Stock Forecast FAQ
In the current month, PKTX has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The PKTX average analyst price target in the past 3 months is --.
-
Where Will Protokinetix, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Protokinetix, Inc. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Protokinetix, Inc.?
Analysts are divided on their view about Protokinetix, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Protokinetix, Inc. is a Sell and believe this share price will rise from its current level to --.
-
What Is Protokinetix, Inc.'s Price Target?
The price target for Protokinetix, Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is PKTX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Protokinetix, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of PKTX?
You can purchase shares of Protokinetix, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Protokinetix, Inc. shares.
-
What Is The Protokinetix, Inc. Share Price Today?
Protokinetix, Inc. was last trading at $0.0100 per share. This represents the most recent stock quote for Protokinetix, Inc.. Yesterday, Protokinetix, Inc. closed at $0.0082 per share.
-
How To Buy Protokinetix, Inc. Stock Online?
In order to purchase Protokinetix, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get PKTX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PKTX
Sector
P/E ratio
23.85x
23.16x
PEG ratio
-0.75x
-0.01x
P/B ratio
13.02x
1.73x
Price / LTM sales
--
1.50x
Growth Metrics
PKTX
Sector
Revenue growth
--
3.24%
Earnings growth
--
11.06%
Revenue (5-year growth)
--
6.28%
Earnings forecast
--
-$0.19
Profitability
PKTX
Sector
Profitability FY 2024
-$52.9K
$2.7M
Return on invested capital
-111.59%
-33.62%
Return on assets
-77.54%
-29.68%
Return on equity
-111.59%
-39.33%
Earnings Date
Last Earnings Date
Feb
14
Next Earnings Date
Feb
14
Estimated Next Earnings Date
May
16
Balance Sheet
PKTX
Sector
Total cash
$600
$25.1M
Short term investments
--
$23.9M
Total assets
$466.1K
$72.8M
Long term debt
--
$2.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 64x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
44
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
77
CPS alert for Feb 14
Cooper-Standard Holdings, Inc. [CPS] is up 32.06% over the past day.
Buy
91
SPHR alert for Feb 14
Sphere Entertainment Co. [SPHR] is down 0.2% over the past day.
Sell
39
IRON alert for Feb 14
Disc Medicine, Inc. [IRON] is down 21.88% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
